Rubella Virus Vaccine Live

From Anvita Health Wiki

Contents 1 Indications 2 Contraindications 3 Dosage 4 Test-interactions 5 More General Terms 6 Additional Terms 7 References

Indications

• vaccine-induced immunity to rubella

Contraindications

• hypersensitivity to neomycin
• pregnancy
• patients receiving immunosuppressive agents
• patients receiving radiation therapy

• Caution:

• females should avoid pregnancy for 3 months afer vaccination
• defer vaccination for 3 months following plasma transfusions or administration of immune globulin or immunosuppressive drugs

Dosage

• Injection: 1000 TCID50 of rubella (Wistar RA 27/3 Strain) Adverse reactions:
• common (> 10%)

• arthralgias
• local tenderness & erythema
• urticaria
• rash
• joint pain 1-10 weeks after vaccination, persisting 1-3 days

• less common (1-10%)

• malaise, fever, headache, sore throat, lymphadenopathy

• uncommon (< 1%)

• hypersensitivity, allergic reactions to vaccine, optic neuritis

Test-interactions

• temporary suppression of TB skin test reactivity

More General Terms

• vaccine

Additional Terms

• measles & rubella combined vaccine (M-R-VAX II)
• measles, mumps & rubella combined vaccine (MMR)
• rubella (German measles, 3rd disease)

References

1. Kaiser Permanente Northern California Regional Drug Formulary, 1998
2. Department of Veterans Affairs, VA National Formulary

rubella virus vaccine, live (Meruvax II)